Cervical cancer (n = 44) | |
---|---|
 Histological diagnosis, %, (n) | |
  Adenocarcinoma | 20.5 (9) |
  Squamous cell carcinoma | 77.3 (34) |
  Unknown | 2.3 (1) |
 FIGO classification (2008), %, (n) | |
  Stage I | 77.3 (34) |
  Stage II | 15.9 (7) |
 Stage III | 4.5 (2) |
  Stage IV | 2.3 (1) |
Endometrial (n = 58) | |
 Histological diagnosis, %, (n) | |
  Adenocarcinoma | 89.7 (52) |
  Squamous cell carcinoma | 1.7 (1) |
  Unknown | 6.9 (4) |
 FIGO classification (2008), %, (n) | |
  Stage I | 75.9 (44) |
  Stage II | 3.4 (2) |
  Stage III | 15.5 (9) |
  Stage IV | 0 (0) |
  Unknown | 5.2 (3) |
Ovarian (n = 37) | |
 Histological diagnosis, %, (n) | |
  Adenocarcinoma | 78.4 (29) |
  Squamous cell carcinoma | 5.4 (2) |
  Unknown | 16.2 (6) |
 FIGO classification (2008), %, (n) | |
  Stage I | 54.1 (20) |
  Stage II | 5.4 (2) |
  Stage III | 13.5 (5) |
  Stage IV | 16.2 (6) |
  Unknown | 10.8 (4) |
Peritoneal (n = 4) | |
 Histological diagnosis, %, (n) | |
  Adenocarcinoma | 75.0 (3) |
  Squamous cell carcinoma | 0 (0) |
  Unknown | 25.0 (1) |
 FIGO classification (2008), %, (n) | |
  Stage III | 50.0 (2) |
  Stage IV | 50.0 (2) |